Description
Spnib 70mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer. The active ingredient, likely a tyrosine kinase inhibitor, works by blocking specific proteins that cancer cells need to grow and divide. By inhibiting these pathways, Spnib helps to slow down or stop the progression of the disease.
This medication is indicated for the treatment of specific cancers, as determined by your physician. It is crucial to follow the prescribed dosage and administration instructions carefully. The typical dosage is 70mg once daily, but this may be adjusted based on individual response and tolerance. It is usually taken with or without food.
Common side effects may include fatigue, nausea, diarrhea, rash, and decreased appetite. More serious side effects can occur, so it is important to report any unusual symptoms to your doctor immediately. Spnib 70mg Tablet should be stored at room temperature, away from moisture and direct heat. Keep out of reach of children.
